Complications of portal hypertension, including ascites, gastrointestinal bleeding, hepatic
hydrothorax, and hepatic encephalopathy, are associated with significant morbidity and …

A host of novel renal biomarkers have been developed over the past few decades which
have enhanced monitoring of renal disease and drug-induced kidney injury in both …

Background and aims Portal hypertensive gastropathy (PHG) is common in patients with
cirrhosis and may cause bleeding. This study systematically explored the independent …

Background Patients with decompensated cirrhosis experience high mortality rates. Current
prognostic scores, including the model for end-stage liver disease (MELD), may …

Background & Aims Macrophage migration inhibitory factor (MIF) is an inflammatory cytokine
and an important regulator of innate immune responses. We hypothesised that serum …

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective intervention for portal
hypertensive complications, but its effect on renal function is not well characterized. Here we …

The microbiota in individual habitats differ both in relative composition and absolute
abundance. While sequencing approaches determine only the relative abundances of taxa …

BACKGROUND Individuals with refractory ascites in the context of liver cirrhosis typically
face an adverse prognosis. The transjugular intrahepatic portosystemic shunt (TIPS) is an …

Der transjuguläre intrahepatische portosystemische Shunt (TIPS) wird seit 30 Jahren in der
Therapie der portalen Hypertonie erfolgreich eingesetzt. In nationalen und internationalen …

Background Gastrointestinal bleedings (GIBs) are frequent in cirrhotic patients and lead to
high morbidity and mortality. Lately, there have been conflicting reports on the role of and …